Stockreport

Gilead Sciences to Acquire Arcellx in $7.8 Billion Deal [Yahoo! Finance]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF Gilead Sciences (GILD) on Monday agreed to acquire cancer therapy developer Arcellx (ACLX) in a deal [Read more]